Sidarth Wakhlu, MD

  • 2Articles
  • 3.5KReads1
  • 2000–2025Active
  • 14Collaborators
  • 2Citations2

About

Sidarth Wakhlu, MD, is affiliated with the Center for Depression Research and Clinical Care at the Peter O’Donnell Jr. Brain Institute and the Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas. Wakhlu has published research on addiction, major depressive disorder, and neurology, including studies on the use of naltrexone-bupropion for methamphetamine use and the treatment of interictal psychoses. Contributions span from 2000 to 2025, with frequent collaboration alongside Abu Minhajuddin, Allen R. Wyler, Dietrich Blumer, Edward V. Nunes, and Gavin Bart.

Publications

JCP
Early Change in Depressive Symptom Severity with Naltrexone-Bupropion Combination and Its Association with Reduction in Methamphetamine Use: ADAPT-2 Trial
Original Research

Early Change in Depressive Symptom Severity with Naltrexone-Bupropion Combination and Its Association with Reduction in Methamphetamine Use: ADAPT-2 Trial

July 30, 2025

Improvement in depression accounted for approximately 25% of the treatment effect of naltrexone-bupropion on methamphetamine treatment response.
, , , et al
JCP
Original Research

Treatment of the Interictal Psychoses

July 31, 2000

, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe